Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 49
Filtrar
Más filtros

Banco de datos
Tipo del documento
Intervalo de año de publicación
1.
Pathologe ; 40(Suppl 3): 306-310, 2019 Dec.
Artículo en Alemán | MEDLINE | ID: mdl-31807842

RESUMEN

The article offers a new approach to the retirement of Herxheimer as head of the German Society of Pathology in 1933 and frames it in a new context. The result is that the German Society of Pathology of the time contributed to National Socialism and supported it. Herxheimer became a victim, but his tragic fate was partly self-inflicted. This article is based on the methods of historical and cultural studies.


Asunto(s)
Nacionalsocialismo , Patología/historia , Alemania , Historia del Siglo XX , Humanos
2.
HNO ; 62(5): 342-9, 2014 May.
Artículo en Alemán | MEDLINE | ID: mdl-24633392

RESUMEN

BACKGROUND: The number of elderly patients with head and neck cancer is increasing. However, there are few valid data on postoperative course after head and neck cancer surgery in elderly patients. The aim of this study was to evaluate the oncological outcome of elderly patients after surgical treatment for oro- and hypopharyngeal cancer. MATERIAL AND METHODS: The clinical data of 81 patients, separated into two age groups (62 < 65 years vs. 19 ≥ 65 years), were retrospectively analysed. The cohort comprised T1 and T2 oro- and hypopharyngeal cancer patients, who had undergone primary treatment with transoral laser surgery and neck dissection. Overall and disease-free survival times of the patients were analysed. Additionally, comorbidities and perioperative complications were compared between the two age groups. Median follow-up time was 5.9 years. RESULTS: Comparison of different clinical and histopathological data revealed no significant differences between the age groups. The Kaplan-Meier method revealed no significant difference in disease-free survival between the age groups (p = 0.52). Age had no effect on disease-free survival in uni- or multivariate analysis (p = 0.53 vs. 0.94). Surgery-related complications were observed in 13 patients (16 %), 11 cases of which concerned the younger group of patients. CONCLUSION: Transoral laser surgery and neck dissection can lead to satisfactory oncological and surgical outcomes in elderly patients with oro- and hypopharyngeal cancer.


Asunto(s)
Neoplasias Hipofaríngeas/cirugía , Terapia por Láser/métodos , Disección del Cuello/métodos , Neoplasias Orofaríngeas/cirugía , Anciano , Anciano de 80 o más Años , Supervivencia sin Enfermedad , Femenino , Humanos , Neoplasias Hipofaríngeas/diagnóstico , Masculino , Persona de Mediana Edad , Neoplasias Orofaríngeas/diagnóstico , Procedimientos Quirúrgicos Otorrinolaringológicos/métodos , Estudios Retrospectivos , Resultado del Tratamiento
3.
Invest New Drugs ; 28(2): 145-55, 2010 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-19238326

RESUMEN

Trabectedin is a novel anticancer drug active against soft tissue sarcomas. Trabectedin is a substrate for P-glycoprotein (P-gp), which is encoded by mdr1a/1b in rodents. Plasma and tissue distribution, and excretion of [(14)C]-trabectedin were evaluated in wild-type and mdr1a/1b(-/-) mice. In parallel, we investigated the toxicity profile of trabectedin by serial measurements of blood liver enzymes and general pathology. [(14)C]-trabectedin was extensively distributed into tissues, and rapidly converted into a range of unknown metabolic products. The excretion of radioactivity was similar in both genotypes. The plasma clearance of unchanged trabectedin was not reduced when P-gp was absent, but organs under wild type circumstances protected by P-gp showed increased trabectedin concentrations in mdr1a/1b(-/-) mice. Although hepatic trabectedin concentrations were not increased when P-gp was absent, mdr1a/1b(-/-) mice experienced more severe liver toxicity. P-gp plays a role in the in vivo disposition and toxicology of trabectedin.


Asunto(s)
Miembro 1 de la Subfamilia B de Casetes de Unión a ATP/deficiencia , Miembro 1 de la Subfamilia B de Casetes de Unión a ATP/genética , Dioxoles/farmacocinética , Dioxoles/toxicidad , Tetrahidroisoquinolinas/farmacocinética , Tetrahidroisoquinolinas/toxicidad , Animales , Área Bajo la Curva , Dioxoles/química , Dioxoles/metabolismo , Relación Dosis-Respuesta a Droga , Femenino , Hígado/efectos de los fármacos , Hígado/enzimología , Hígado/patología , Masculino , Dosis Máxima Tolerada , Ratones , Ratones Noqueados , Tetrahidroisoquinolinas/química , Tetrahidroisoquinolinas/metabolismo , Distribución Tisular/efectos de los fármacos , Trabectedina
4.
Bone Marrow Transplant ; 41(8): 743-7, 2008 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-18176614

RESUMEN

Prospective population-based surveillance to assess the epidemiology of invasive pneumococcal disease (IPD) in hematopoietic stem cell transplant (HSCT) patients is limited and a comparison to the general population is lacking. By using a population-based Invasive Bacterial Diseases Network surveillance program, we studied the incidence, clinical significance, serotypes and antimicrobial resistance of IPD in a large cohort of adult HSCT patients and the general population. Streptococcus pneumoniae isolates and patient data were collected prospectively from 1995 to 2004. We identified 14 cases of IPD (based on sterile site isolates) in our HSCT population over a 10-year period. This translated to an incidence rate of 347 infections per 100 000 persons per year. This compared to an incidence of 11.5 per 100 000 persons per year in the general population (regression ratio=30.2; 95% confidence interval (CI) 17.8-50.8, P<0.00001). If nonsterile site isolates (respiratory tract) were included, the incidence rate in transplant patients was 446 per 100 000 persons per year. Serotypes 23F and 6B were most common; 100 and 69.2% of isolates were a serotype included in the pneumococcal polysaccharide and conjugate vaccines, respectively. The antimicrobial resistance rates were high, especially for trimethoprim/sulfamethoxazole. HSCT recipients are at significantly greater risk for IPD than the general population. Preventative strategies are necessary.


Asunto(s)
Bacteriemia/epidemiología , Trasplante de Células Madre Hematopoyéticas/efectos adversos , Neumonía Neumocócica/epidemiología , Vigilancia de Guardia , Streptococcus pneumoniae/patogenicidad , Adulto , Femenino , Humanos , Incidencia , Masculino , Persona de Mediana Edad , Ontario/epidemiología , Estudios Prospectivos
5.
J Hum Hypertens ; 21(6): 486-93, 2007 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-17330056

RESUMEN

Aerobic physical exercise is broadly recommended as a helpful adjunct to obtain blood pressure control in hypertension. Beta-blockade interacts with heart rate, sympathetic tone, maximal workload and local lactate production. In the present randomized-controlled study, we compared the cardiovascular effects of an endurance training programme in elderly hypertensives with or without beta-blockers and developed a first approach to determine a lactate-based training heart rate in presence of beta-blockade. Fifty-two patients (23 with beta-blocker, 29 without beta-blocker) > or =60 years with systolic 24-h ambulatory blood pressure (ABP) > or =140 mm Hg and/or antihypertensive treatment were randomly assigned to sedentary activity or a heart-rate controlled 12-week treadmill exercise programme (lactate 2.0 mmol/l). In the exercise group, the training significantly decreased systolic and diastolic 24-h ABP, blood pressure on exertion (100 W) and increased endothelium-dependent vasodilation (flow-mediated vasodilation, FMD) and physical performance both in the presence and absence of beta-blockade (P<0.05 each). The extent of ABP reduction did not significantly differ in the presence or absence of beta-blockade (Delta systolic ABP 10.6+/-10.5 vs 10.6+/-8.8 mm Hg, Delta diastolic ABP 5.7+/-8.6 vs 5.8+/-4.0 mm Hg). Mean training heart rate was significantly lower in the patients on beta-blockers (97.2+/-7.7 vs 118.3+/-7.5/min, P<0.001). Lactate-based aerobic endurance training evokes comparable cardiovascular benefits in the presence and absence of beta-blockade including a marked improvement of endothelial function. In the present study, target training heart rate with beta-blockers is about 18% lower than without.


Asunto(s)
Antagonistas Adrenérgicos beta/uso terapéutico , Antihipertensivos/uso terapéutico , Hipertensión/tratamiento farmacológico , Resistencia Física/efectos de los fármacos , Esfuerzo Físico/efectos de los fármacos , Anciano , Presión Sanguínea/efectos de los fármacos , Células Endoteliales/fisiología , Femenino , Corazón/fisiología , Frecuencia Cardíaca/efectos de los fármacos , Humanos , Masculino , Resistencia Física/fisiología , Esfuerzo Físico/fisiología , Vasodilatación/efectos de los fármacos
6.
Acta Otorhinolaryngol Ital ; 36(4): 310-316, 2016 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-27734984

RESUMEN

Due to an increasing number of cochlear implantations, quality control has become more important. In addition to intraoperative biophysical measurements, radiological imaging is another possibility. An upcoming technique regarding this is Cone Beam CT (CBCT). Sixty-five data sets (35 Nucleus Contour Advance-Cochlear; 30 Flex Soft-MedEl) of postoperative imaging by CBCT (Accu-I-tomo F17, Morita, Kyoto, Japan) underwent further evaluation. Insertion angle, height of the cochlea, distance of the electrode to the medial or lateral wall, angle between chorda tympani and facial nerve and the precise position of the electrode cable in the facial-chordal angle were determined. The typical difference between the perimodiolar and lateral course of the electrodes could also be shown in radiological measurements. This demonstrates the accuracy and advantage of CBCT in visualisation of small structures with fewer metal artifacts. Furthermore, in 75% of patients, the angle of the chorda and facial nerve could be visualised. Significant differences in dependence of the electrode type for the relation of them to the facial nerve could be seen. In conclusion, CBCT achieves reliable visualisation and detailed imaging-based measurements of the intracochlear position of different cochlea electrodes. Additionally, clinically known differences can be reproduced. Even visualisation of the position of the electrode in the chorda-facial angle is possible. Therefore, CBCT is a useful tool in intra- and postoperative control of cochlear implants.


Asunto(s)
Cóclea/diagnóstico por imagen , Implantación Coclear/métodos , Tomografía Computarizada de Haz Cónico , Cirugía Asistida por Computador , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Niño , Preescolar , Cóclea/anatomía & histología , Implantes Cocleares , Femenino , Humanos , Masculino , Persona de Mediana Edad , Adulto Joven
7.
Bone Marrow Transplant ; 50(1): 95-9, 2015 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-25285800

RESUMEN

Numerous studies have reported the feasibility and safety of autologous SCT (ASCT) in patients with multiple myeloma (MM) and mild to moderate renal impairment, but there are limited data in dialysis-dependent patients. In this retrospective study, we reviewed the toxicities and efficacy outcomes of 33 MM patients with dialysis-dependent renal failure who underwent ASCT at our institution from 1998 to 2012. The most common grade 3 non-hematologic toxicities were mucositis (49%), infection (15%) and bleeding (6%). Atrial dysrhythmias (24%) and delirium (30%) of all grades were also common. Hematologic toxicities included febrile neutropenia (88%); and RBC and platelet transfusions were required by 71 and 100% of patients, respectively. Transplant-related mortality (TRM) was high at 15%, predominantly caused by septic shock. Response to ASCT was at least VGPR (very good PR) in 50%, PR in 46.2% and stable disease (SD) in 3.8%. Median OS was 5.6 years, comparable to our overall institutional data. Overall, seven patients became dialysis independent. We conclude that ASCT can be an effective treatment for dialysis-dependent MM patients, with high response rates and survival. However, toxicities and a high TRM are observed indicating that further studies are needed to enhance the safety of this approach.


Asunto(s)
Mieloma Múltiple , Diálisis Renal , Insuficiencia Renal , Trasplante de Células Madre , Adulto , Anciano , Autoinjertos , Bases de Datos Factuales , Humanos , Masculino , Persona de Mediana Edad , Mieloma Múltiple/complicaciones , Mieloma Múltiple/mortalidad , Mieloma Múltiple/terapia , Insuficiencia Renal/complicaciones , Insuficiencia Renal/mortalidad , Insuficiencia Renal/terapia , Estudios Retrospectivos , Tasa de Supervivencia
8.
Bone Marrow Transplant ; 33(3): 271-7, 2004 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-14647248

RESUMEN

Autologous stem cell transplantation (ASCT) for primary systemic amyloidosis (AL) produces high hematologic and organ responses. However, treatment-related mortality remains high and reported series are subject to selection bias. In all, 48 of 80 amyloid patients referred to our center had AL in the absence of myeloma, 26 of these 48 were deemed transplant candidates and 20 actually underwent ASCT. Transplant-related mortality has fallen from 50 to 20% since January 1999 due to better patient selection and prophylactic measures. Intent-to-treat organ responses were renal (46%), cardiac (25%) and liver (50%). Organ responses in patients who survived transplantation were renal (75%), cardiac (40%) and liver (100%). The 3-year OS post-ASCT was 56% with improved outcome predicted by a better performance status (P=0.08), normal ALP (P=0.08), nephrotic syndrome (P=0.01) and the absence of severe hypotension (P=0.01). The 3-year OS for all referred patients was 44% and this was not significantly better for transplant candidates. Patients with significant hypotension (systolic blood pressure < or =90 mmHg) or poor performance status (ECOG >2) have an exceedingly high treatment-related mortality and should not be transplanted. For those undergoing ASCT, organ response rates appear promising, but conclusive evidence of improved survival for this select group of patients is still lacking and will require randomized trials.


Asunto(s)
Amiloidosis/terapia , Trasplante de Células Madre Hematopoyéticas/mortalidad , Selección de Paciente , Adulto , Anciano , Amiloidosis/complicaciones , Amiloidosis/mortalidad , Femenino , Cardiopatías/etiología , Cardiopatías/terapia , Trasplante de Células Madre Hematopoyéticas/efectos adversos , Trasplante de Células Madre Hematopoyéticas/métodos , Humanos , Hipotensión/etiología , Hipotensión/terapia , Enfermedades Renales/etiología , Enfermedades Renales/terapia , Hepatopatías/etiología , Hepatopatías/terapia , Masculino , Persona de Mediana Edad , Síndrome Nefrótico/etiología , Síndrome Nefrótico/terapia , Estudios Retrospectivos , Análisis de Supervivencia , Trasplante Autólogo , Resultado del Tratamiento
9.
Intensive Care Med ; 28(5): 622-8, 2002 May.
Artículo en Inglés | MEDLINE | ID: mdl-12029412

RESUMEN

OBJECTIVE: As bolus instillation of surfactant can lead to acute pulmonary, hemodynamic and cerebral side effects, we tested whether pulmonary mechanics and gas exchange differ between slow surfactant infusion and bolus administration. DESIGN AND SETTING: Prospective, randomized pilot study in a tertiary care university hospital. PATIENTS AND METHODS: Of 20 consecutive preterm infants (27-35 weeks' gestation) with severe respiratory distress syndrome) who were enrolled 14 with bovine surfactant finally were analyzed. INTERVENTIONS: Six treatments were administered by slow endotracheal surfactant infusion and eight as a bolus. Static compliance (C(stat)) and resistance (R(rs)) were measured every 3 min. RESULTS: C(stat) first decreased and then increased in both groups. In the infusion group C(stat) after 90 min was significantly higher than after bolus treatment but not after 15 or 45 min. R(rs) increased about threefold, with large fluctuations in the bolus group. After 90 min PaO(2)/FIO(2) had increased from 111+/-44 to 254+/-69 in the bolus group and from 86+/-40 to 238+/-102 in the infusion group, but early FIO(2) reduction and increase in PaO(2)/FIO(2) seemed delayed in the infusion group. CONCLUSIONS: Very slow infusion of natural surfactant is at least as effective as bolus instillation in terms of improvement in C(stat) and oxygenation after 90 min. However, until 90 min the course of C(stat) and indices of gas exchange seem superior after bolus therapy. Because R(rs) is substantially increased, long expiratory times are required to yield complete exhalation.


Asunto(s)
Surfactantes Pulmonares/administración & dosificación , Insuficiencia Respiratoria/tratamiento farmacológico , Insuficiencia Respiratoria/fisiopatología , Resistencia de las Vías Respiratorias/efectos de los fármacos , Humanos , Recién Nacido , Recien Nacido Prematuro , Instilación de Medicamentos , Rendimiento Pulmonar/efectos de los fármacos , Proyectos Piloto , Estudios Prospectivos , Intercambio Gaseoso Pulmonar/efectos de los fármacos , Pruebas de Función Respiratoria , Mecánica Respiratoria/efectos de los fármacos , Estadísticas no Paramétricas
10.
Intensive Care Med ; 7(3): 133-8, 1981 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-6971304

RESUMEN

Ten anesthetized mongrel dogs had a left anterolateral thoracotomy; the left anterior descending coronary artery was then ligated. After 60 min five animals each were treated either with dobutamine (4 microgram/min/kg; for 10 min), or with dobutamine and intraaortic counterpulsation. Combined treatment of cardiogenic shock proved superior. Those five dogs had significantly lower heart rates and dp/dt/p-values. Due to IABP the non-ischemic parts of the left ventricle were better perfused; there was no difference in treatment with regard to ischemic parts. The combined treatment was successfully inaugurated in two patients with cardiogenic shock.


Asunto(s)
Circulación Asistida , Catecolaminas/administración & dosificación , Dobutamina/administración & dosificación , Contrapulsador Intraaórtico , Choque Cardiogénico/terapia , Adulto , Animales , Puente de Arteria Coronaria , Circulación Coronaria/efectos de los fármacos , Vasos Coronarios/cirugía , Perros , Hemodinámica/efectos de los fármacos , Humanos , Persona de Mediana Edad , Choque Cardiogénico/fisiopatología
11.
Artículo en Inglés | MEDLINE | ID: mdl-6578565

RESUMEN

UNLABELLED: Changes of total (Ca) and ionized Ca-levels (Ca2+) were studied during open heart surgery in 18 patients. 9 patients (group A) had only crystalloid solutions as pump priming, the other 9 patients (group B) had 500 ml of citrated whole blood in the priming solution. For assessment of hemodilution hct and total plasma protein and plasma albumin were determined. Measurements were done preoperatively, before and after systemic heparinisation, during and after extracorporeal circulation (ECC) and on the first postoperative day. RESULTS: 1. Anticoagulation with 375 U/kg BW heparin had no effect on ionized calcium levels. 2. With onset of ECC (Ca) decreased by 30% in group A and by 20% in group B. (Ca2+), however, decreased by 20% in group A and by 35% in group B. The percentage of ionized calcium increased by 15% in group A whereas it decreased by the same amount in group B. This difference is contributed to the calcium binding effect of citrate added to pump priming in group B. Mechanisms of the relative increase of ionized calcium during ECC in group A, however, remain to be studied.


Asunto(s)
Calcio/sangre , Circulación Extracorporea , Glucemia , Proteínas Sanguíneas/metabolismo , Transfusión Sanguínea , Procedimientos Quirúrgicos Cardíacos , Cationes Bivalentes , Citratos/sangre , Glucosa , Hematócrito , Humanos , Unión Proteica
12.
Acta Anaesthesiol Belg ; 30 Suppl: 81-5, 1979.
Artículo en Inglés | MEDLINE | ID: mdl-317625

RESUMEN

In 12 patients with coronary artery disease, hypertensive period during aortocoronary bypass grafting were treated with enflurane. The effects of enflurane on the general hemodynamic and the major determinants of myocardial oxygen consumption were studied. Heart rate and systolic arterial pressure were significant reduced, cardiac index and pulmonary capillary wedge pressure remained unchanged. The calculated determinants of myocardial oxygen consumption decreased, as well as the measured arterial-coronary venous oxygen content difference. The authors conclude, that enflurane can reduce the afterload in patients with coronary heart disease.


Asunto(s)
Enflurano/farmacología , Contracción Miocárdica/efectos de los fármacos , Puente de Arteria Coronaria , Enfermedad Coronaria/fisiopatología , Humanos , Persona de Mediana Edad , Consumo de Oxígeno/efectos de los fármacos
13.
Leukemia ; 26(4): 757-68, 2012 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-21941364

RESUMEN

Proteasome inhibition is a novel treatment for several hematological malignancies. However, resistance to the proteasome inhibitor bortezomib (BTZ, Velcade) is an emerging clinical impediment. Mutations in the ß5 subunit of the proteasome, the primary target of BTZ, have been associated with drug resistance. However, the exact mechanism by which these mutations contribute to BTZ resistance, is still largely unknown. Toward this end, we here developed BTZ-resistant multiple myeloma (8226) and acute lymphoblastic leukemia (CCRF-CEM) cell line models by exposure to stepwise increasing concentrations of BTZ. Characterization of the various BTZ-resistant cells revealed upregulation of mutant ß5 subunit of the proteasome. These newly identified ß5-subunit mutations, along with previously described mutations, formed a mutation cluster region in the BTZ-binding pocket of the ß5 subunit, that of the S1 specificity pocket in particular. Moreover, we provide the first evidence that the mechanism underlying BTZ resistance in these tumor cells is impaired binding of BTZ to the mutant ß5 subunit of the proteasome. We propose that proteasome subunit overexpression is an essential compensatory mechanism for the impaired catalytic activity of these mutant proteasomes. Our findings further suggest that second-generation proteasome inhibitors that target the α7 subunit of the proteasome can overcome this drug resistance modality.


Asunto(s)
Antineoplásicos/metabolismo , Ácidos Borónicos/metabolismo , Mieloma Múltiple/tratamiento farmacológico , Mutación , Leucemia-Linfoma Linfoblástico de Células T Precursoras/tratamiento farmacológico , Complejo de la Endopetidasa Proteasomal/genética , Pirazinas/metabolismo , Sustitución de Aminoácidos , Ácidos Borónicos/uso terapéutico , Bortezomib , Línea Celular Tumoral , Resistencia a Antineoplásicos , Humanos , Mieloma Múltiple/genética , Mieloma Múltiple/patología , Leucemia-Linfoma Linfoblástico de Células T Precursoras/genética , Leucemia-Linfoma Linfoblástico de Células T Precursoras/patología , Complejo de la Endopetidasa Proteasomal/metabolismo , Inhibidores de Proteasoma , Pirazinas/uso terapéutico
14.
Bone Marrow Transplant ; 46(10): 1339-44, 2011 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-21243027

RESUMEN

Our purpose was to assess efficacy and toxicity of high-dose chemotherapy (HDCT) and ASCT in patients with relapsed and refractory Hodgkin's lymphoma (HL) aged 60 years and older and compare the results with a group of younger HL patients treated in a similar manner. We identified 15 consecutive patients, with HL aged 60 years and older who underwent HDCT (etoposide 60 mg/kg+ melphalan 160 mg/m(2)) and ASCT at our institution from May 2001 to March 2008. The results were compared with a cohort of 157 younger HL patients treated in a similar manner from January 1999 to December 2006. After a median follow-up of 2.5 years, PFS at 3 years after ASCT was 73% (95% confidence interval (CI) 37-90) for the older group and 56% (95% CI 46-64) for the younger group (P=0.45); OS after ASCT was 88% (95% CI 39-98) for the older group and 84% (95% CI 75-90) for the younger group (P=0.80). No transplant-related deaths were seen. Our study suggests that ASCT is feasible for selected elderly patients with HL, giving similar results to younger patients in terms of survival and toxicity.


Asunto(s)
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Enfermedad de Hodgkin/tratamiento farmacológico , Enfermedad de Hodgkin/cirugía , Trasplante de Células Madre/métodos , Adolescente , Adulto , Factores de Edad , Anciano , Estudios de Cohortes , Etopósido/administración & dosificación , Femenino , Movilización de Célula Madre Hematopoyética/métodos , Enfermedad de Hodgkin/patología , Humanos , Masculino , Melfalán/administración & dosificación , Persona de Mediana Edad , Terapia Recuperativa , Análisis de Supervivencia , Trasplante Autólogo , Adulto Joven
16.
Pharm Hist ; 24(3): 117-9, 1982.
Artículo en Inglés | MEDLINE | ID: mdl-11615885
17.
Bone Marrow Transplant ; 43(5): 411-5, 2009 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-18936734

RESUMEN

Between January 2001 and July 2006, 1013 patients received autologous hematopoietic cell transplants (AHCT) at Canada's largest transplant center. In this retrospective cohort study of AHCT patients admitted to the intensive care unit (ICU), we describe the outcomes following ICU admission and the variables measured in the first 24 h of ICU admission associated with overall ICU mortality. Results indicate a 3.3% ICU admission rate (n=34) with 13 deaths (1% overall mortality rate, 38% in ICU mortality rate). The worst outcome was in AL amyloid patients of whom 28% were admitted to the ICU, with an ICU mortality rate of 55%. The Sequential Organ Failure Assessment (SOFA) score and Acute Physiology and Chronic Health Evaluation (APACHE II) score in the first 24 h were statistically associated with mortality by univariate analysis. Other variables measured at 24 h and associated with ICU mortality included multiorgan failure, mechanical ventilation, inotropic support >4 h and Gram-negative sepsis. Our data indicate that ICU admission in the autotransplant population is rare and that it is influenced by underlying diagnosis, with AL amyloid patients having the highest risk. Our observations may assist clinical decision-making regarding the continuation of intensive care delivered 24 h after ICU admission.


Asunto(s)
Trasplante de Células Madre Hematopoyéticas/mortalidad , Adulto , Anciano , Femenino , Mortalidad Hospitalaria , Humanos , Unidades de Cuidados Intensivos , Masculino , Persona de Mediana Edad , Insuficiencia Multiorgánica/mortalidad , Respiración Artificial/mortalidad , Estudios Retrospectivos , Trasplante Autólogo
18.
Bone Marrow Transplant ; 42(11): 733-7, 2008 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-18711349

RESUMEN

Peripheral blood hematopoietic progenitor cells (PBHC) are the standard source of support for high-dose chemotherapy because of faster recovery of marrow function. Unfortunately, a proportion of patients are unable to mobilize adequate progenitors to proceed to autologous hematopoietic cell transplant (AHCT). Granulocyte-CSF-stimulated BM-derived hematopoietic progenitor cells (BMHC) may circumvent this problem. From 1999 to 2006, 52 patients (cases) with AML, Hodgkin (HL) or non-Hodgkin's lymphoma (NHL) in whom PBHC mobilization failed underwent a G-CSF-stimulated bone marrow harvest and proceeded to AHCT. Their outcome was compared with 422 patients (controls) with AML, HL and NHL undergoing AHCT using only PBHC. Twenty-three patients received BMHC alone and 29 patients received a combination of PBHC and BMHC. Median engraftment time for neutrophils (>0.5 x 10(9)/l) and platelets (>20 x 10(9)/l) were 14 and 27 days, but significantly longer when compared with controls (11 days, 11 days, P<0.0001). Patients receiving both PBHC and BMHC had faster engraftment, when compared with those receiving BMHC alone (P<0.001). In conclusion, performing an AHCT using G-CSF-stimulated BMHC in patients failing PBHC collection is feasible with faster engraftment seen in patients receiving both BMHC and PBHC over BMHC alone.


Asunto(s)
Trasplante de Médula Ósea/métodos , Factor Estimulante de Colonias de Granulocitos/metabolismo , Células Madre/citología , Adulto , Anciano , Femenino , Neoplasias Hematológicas/terapia , Movilización de Célula Madre Hematopoyética/métodos , Células Madre Hematopoyéticas/citología , Humanos , Masculino , Persona de Mediana Edad , Neutrófilos/citología , Factores de Tiempo , Resultado del Tratamiento
19.
Anasth Intensivther Notfallmed ; 18(6): 285-90, 1983 Dec.
Artículo en Alemán | MEDLINE | ID: mdl-6666841

RESUMEN

The microcirculatory effects of halothane and enflurane were studied in a new experimental model before, during and after anaesthesia. It was only with complete volume substitution and a constant CVP during anaesthesia that blood cell velocity and capillary perfusion remained unchanged, whereas functional capillary density shifted the histogram of local pO2 to the right, i.e. towards increased pO2 values. Spontaneous arteriolar vasomotion was inhibited during anaesthesia with halothane and enflurane. The study also shows that homogeneous capillary perfusion and microcirculatory flow distribution during anaesthesia are closely related to normovolaemia and changes in CVP.


Asunto(s)
Enflurano/farmacología , Halotano/farmacología , Microcirculación/efectos de los fármacos , Anestesia , Animales , Capilares/efectos de los fármacos , Cricetinae , Mesocricetus , Oxígeno/sangre , Factores de Tiempo
20.
Onkologie ; 12(3): 143-7, 1989 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-2503798

RESUMEN

Based on previously published experimental studies in nude mice indicating that rTNF-alpha as well as mitomycin C are able to induce significant growth inhibition of xenotransplants of gastrointestinal and pancreatic carcinomas we have investigated the antitumor effects of rTNF-alpha (0.8 mg/kg daily for 21 days) and mitomycin C (2.4 mg/kg once weekly, day 1, 7, 14) as single drugs and in combination (0.8 + 2.4) in nude mice bearing xenografts of 4 human pancreatic carcinomas and 1 colorectal cancer. Serum CA 19-9 was measured additionally to tumor growth rate. The results demonstrate that combined treatment is more effective compared to rTNF-alpha and mitomycin C alone. Combined therapy resulted in a significant inhibition of tumor growth in 3 of 5 xenografts and in decrease of tumor volume to less than 50% of the initial values in 2 of 5 tumors. The results support the concept that combinations of cytokines with cytostatics might be of value for treatment of gastrointestinal and pancreatic cancer in vivo.


Asunto(s)
Mitomicinas/uso terapéutico , Neoplasias Pancreáticas/terapia , Factor de Necrosis Tumoral alfa/uso terapéutico , Animales , Antígenos de Carbohidratos Asociados a Tumores/análisis , División Celular/efectos de los fármacos , Neoplasias Colorrectales/terapia , Terapia Combinada , Humanos , Ratones , Ratones Endogámicos BALB C , Ratones Desnudos , Mitomicina , Trasplante de Neoplasias , Proteínas Recombinantes/uso terapéutico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA